Artura Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.77 Cr
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.14 Cr
- Revenue Growth -9.57%
- Profit Growth -83.35%
- Ebitda -14.82%
- Net Worth 17.05%
- Total Assets 5.76%
About Artura Pharmaceuticals
Artura Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 February 2010 and has a history of 14 years and 11 months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.77 Cr.
The company currently has active open charges totaling ₹22.14 Cr.
Damodaram Harirajan, Pushpakala Harirajan, and Vikram Harirajan serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233TN2010PTC074560
-
Company No.
074560
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Feb 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Artura Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Harirajan
|
Managing Director | 10-Feb-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Damodaram Harirajan
|
Director | 10-Feb-2010 | Current |
|
Pushpakala Harirajan
|
Director | 10-Feb-2010 | Current |
Financial Performance of Artura Pharmaceuticals.
Artura Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.57% decrease. The company also saw a substantial fall in profitability, with a 83.35% decrease in profit. The company's net worth Soared by an impressive increase of 17.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Artura Pharmaceuticals?
In 2023, Artura Pharmaceuticals had a promoter holding of 48.37% and a public holding of 51.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Axon Drugs Private LimitedDamodaram Harirajan, Pushpakala Harirajan and 1 more are mutual person
Charges (Loans)
₹22.14 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 22.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2021 | Indian Overseas Bank | ₹2.89 Cr | Open |
| 22 Jul 2013 | Indian Overseas Bank | ₹19.25 Cr | Open |
How Many Employees Work at Artura Pharmaceuticals?
Artura Pharmaceuticals has a workforce of 64 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Artura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artura Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
